Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Shire PLC

+1 (617) 349-0200
Website

Advertisement

Advertisement

300 Shire Way
Lexington, MA 02421
+1 (617) 349-0200
https://www.takeda.com
Shire Specialty Pharmaceuticals is a division of Shire, which offers products under the VYVANSE, DAYTRANA, ADDERALL, FOSRENOL, AGRYLIN, ELAPRASE and PENTASA brand names for the treatment attention deficit hyperactivity disorder. The division sells its products to several pharmaceutical wholesale distributors and pharmacies in the United States and Europe. Founded in 1994, Shire is one of the leading specialty biopharmaceutical companies that focuses on meeting the needs of specialist physicians in Pennsylvania. The parent company has a staff of more than 1,600 employees. Shire s subsidiaries include Shire Human Genetic Therapies UK Limited, Shire Human Genetic Therapies Securities Corporation, Shire Investments & Finance (U.K.) Company, Shire Pharmaceutical Contracts Limited and Shire Intellectual Property 2 SRL.

Also at this address

HCL

Development Media International

Dyax Corp

Takeda

Find related places

Lawyers

Lawyers

Own this business?
Claim it
See a problem?

You might also like

Drugs and drug proprietaries, Drugs acting on the respiratory system, Surgical instruments and apparatus

Dusa Pharmaceuticals

DUSA Pharmaceuticals is a biopharmaceutical research and development company engaged in the development and marketing of its proprietary Levulan photodynamic and Levulan photodetection therapies for the treatment of multiple medical conditions. These products, when delivered to target tissues, are converted by fast growing cells into protoporphyrin IX, a potent photosensitizer, which can then be activated by an appropriate light source. The company s primary focus is in the area of dermatology. Both Levulan photodynamic and Levulan photodetection therapies utilize light-activated compounds to induce a therapeutic or detection effect. DUSA also markets Levulan Kerastick, a 20 percent topical solution that is part of a photodynamic therapy system to treat actinic keratoses, and BLU-U, a blue light photodynamic therapy illuminator that is intended for the treatment of nonhyperkeratotic actinic keratoses of the face or scalp. DUSA Pharmaceuticals maintains its corporate headquarters in Wilmington, Mass., and operates satellite offices in Valhalla, N.Y., and Toronto.
Business services, nec, nec, Feathers and feather products, Drugs acting on the respiratory system

Sunovion

Sunovion Pharmaceuticals Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development and commercialization of pharmaceutical products directed toward serving unmet medical needs. The company s drug development program has yielded a portfolio of pharmaceutical compounds with a focus on respiratory and central nervous system disorders. Its commercialization efforts are carried out by a United States-based nearly 1,250-person primary care and specialty sales force through co-promotion agreements and through out-licensing partnerships. Sunovion Pharmaceuticals selects development compounds with the potential to offer improvements over existing therapies with respect to efficacy, side-effect profile, dosage forms and, in some cases, the opportunity for additional indications. The focus of its discovery effort is to identify additional drug candidates that are directed toward treating respiratory and central nervous system disorders. These compounds are expected to complement Sunovion Pharmaceuticals pharmaceutical pipeline. Sunovion Pharmaceuticals is headquartered n Marlborough, Mass.
Drugs acting on the respiratory system, Surgical instruments and apparatus, Professional equipment, nec, nec

Fresenius Medical Care North America

Fresenius Medical Care North America is part of Fresenius Medical Care, one of the world's largest, integrated providers of products and services for individuals with chronic kidney failure, a condition that affects more than 1.5 million individuals worldwide. Through its network of over 2,220 dialysis clinics in North America, Europe, Latin America and Asia-Pacific, Fresenius Medical Care provides dialysis treatment to 172,227 patients around the globe. Fresenius Medical Care is also the world's largest provider of dialysis products, such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care can trace its roots back to 1462, when The Fresenius family assumed ownership of Hirsch Pharmacy in Frankfurt, Germany. Approximately two-thirds of the company's research and development activities are based in Germany and one-third in North America. The company holds rights to more than 1,100 patents and patent applications relating to dialysis technology in major markets and own trademarks throughout the world.
United States›Massachusetts›Lexington›Shire PLC

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell